The new report “APAC POCT Market Analysis" is expected to reach USD 4.66 billion by 2024 from USD 2.31 billion in 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024.
APAC Point-of-care Testing (POCT) Market Industry By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Country (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines and Rest of APAC) – Trends and Forecast to 2024
The major factors driving the growth of this market include the rising prevalence of modern lifestyle, increase in chronic and infectious diseases, advancement in technology, scope for unmet medical needs and emerging POCT device. These factors increase the demand for devices such as blood glucose meter, CRP, HBA1c, homocystein.
On the other hand, rising costs of POCT device and low reimbursement scenario are regulatory hurdles that may hinder the growth of the market.
Market Segmentation: APAC Point-of-care Testing (POCT) Market
The APAC POCT Device Market Report is segmented on the basis of product type, prescription mode, distribution channel, end user, and geography.
The APAC POCT device market is segmented into twelve product types, such as blood glucose testing kits, cardio metabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others. In 2017, the blood glucose testing kits segment is expected to dominate the market with a share of 24.2% and is expected to continue this trend till 2024.
Cardiometabolic monitoring kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections, and respiratory infections testing kit.
Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.
On the basis of prescription mode, the APAC point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing. The OTC testing is projected to witness higher growth rate of 9.7% during the forecast period to reach a value of USD 1.68 billion by 2024.
On the basis of distribution channel, the APAC point-of-care testing market size is segmented into direct tenders and retail. In 2017, the direct tender market is expected to dominate the market with a value of USD 1.67 billion.
On the basis of end users, the APAC point-of-care testing market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. In 2017, the hospital segment is expected to dominate with the market share of 33.2% and is expected to continue this trend till 2024.
Key Drivers: APAC Point-of-care Testing (POCT) Market
- Rising cost of POCT devices and low reimbursement scenario are the factors which may hinder the growth of this market.
- Many companies are making continuous efforts and advances to make products more relevant, along with propelled innovations with reduced sample volume or less blood on portable devices.
- Scope for unmet medical needs as well as emerging POCT device will drive the market in future.
Key Points: APAC Point-of-care Testing (POCT) Market
Hoffmann La Roche Diagnostics Limited is dominating the APAC POCT device market major players followed by Abbott, Alere Inc., Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics, Instrumentation Laboratory, Nova Biomedical, Beckman Coulter, Inc., Werfenlife and others..
Read more about the APAC Point-of-care Testing (POCT) Market at databridgemarketresearch.com/repor…ting-poct-market/
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: